Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal NutriNeurO logo partenaire Logo Bx INP

NutriNeuro: Integrated Nutrition and Neurobiology Lab

Zone de texte éditable et éditée et rééditée

NutriPsy: Nutrition and Neuropsychiatric symptom dimensions

NutriPsy

Leader: Lucile Capuron, DR1 INRAE lucile.capuron@inrae.fr

Deputy leader: Marie-Pierre Moisan, DR2 INRAE marie-pierre.moisan@inrae.fr

Team presentation

The overarching scientific objective of the Nutripsy team is to understand how nutrition can contribute to mental health, and to identify the mechanisms by which nutritional imbalances promote the development of neuropsychiatric symptoms, focusing on inflammatory processes. For this purpose, we propose a translational and integrative research program with the following complementary specific aims: 

i)               to elucidate the mechanisms by which inflammation, in relation to dietary habits, leads to neuropsychiatric symptom dimensions and antidepressant resistance 

ii)              to determine the influence of environmental factors and genetic variants related to inflammation on depressive symptoms and antidepressant response in clinical and preclinical models of nutritional imbalances, 

iii)              to propose innovative personalized treatment strategies through targeted nutritional approaches guided by the clinical, biological/inflammatory, and nutritional profiles of patients. 

This research program represents a critical step toward a precision medicine applied to mental health, in a context where the efficacy of standard treatments remains mitigated.

Research axes

Axe 8: Nutrition and Mental Health

Axe 6: Psychiatric Pathologies

Researchers

Nathalie Castanon (Chargée de recherche INRAE) 

Muriel Darnaudery (Professeure) 

Sylvie Vancassel (Chargée de recherche INRAE)

Clinicians

Bruno Aouizerate (Professeur Universitaire - Praticien hospitalier) 

Pascal Barat (Professeur Universitaire - Praticien hospitalier) 

Julie Brossaud (Maître de conférences Universitaire - Praticien hospitalier) 

Jean-Benoît Corcuff (Maître de conférences Universitaire - Praticien hospitalier) 

Alexandra Bouvard (Praticien hospitalier Université de Bordeaux) 

Hélène Thibault (Praticien hospitalier Université de Bordeaux) 

Julie Bernard (CCA Université de Bordeaux)

Technicians - Engineers

Sandra Dexpert (AI INRAE)

Aline Foury  (IE INRAE)

Jean-Christophe Helbling (IE INRAE)

Post-docs

Sofia Cussotto (Post-doctorante)

Doctorants

Juliette Montet

Publications

A new experimental design to study inflammation-related versus non-inflammation-related depression in mice. Cardinal P, Monchaux de Oliveira C, Sauvant J, Foury A, Darnaudéry M, Vancassel S, Castanon N, Capuron L.J Neuroinflammation. 2021 Dec 11;18(1):290. 

 

Influence of pro-obesogenic dietary habits on stress-induced cognitive alterations in healthy adult volunteers. Delgado I, Dexpert S, Sauvant J, Cryan JF, Capuron L.

Neurobiol Stress. 2021 Jun 12;15:100353. doi: 10.1016/j.ynstr.2021.100353. eCollection 2021 Nov.

 

Transcriptomic signaling pathways involved in a naturalistic model of inflammation-related depression and its remission.Moisan MP, Foury A, Dexpert S, Cole SW, Beau C, Forestier D, Ledaguenel P, Magne E, Capuron L.Transl Psychiatry. 2021 Apr 6;11(1):203.

 

Saffron Extract-Induced Improvement of Depressive-Like Behavior in Mice Is Associated with Modulation of Monoaminergic Neurotransmission. Monchaux De Oliveira C, Pourtau L, Vancassel S, Pouchieu C, Capuron L, Gaudout D, Castanon N.Nutrients. 2021 Mar 11;13(3):904.

 

Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates. Huet L, Delgado I, Dexpert S, Sauvant J, Aouizerate B, Beau C, Forestier D, Ledaguenel P, Magne E, Capuron L. Brain Behav Immun. 2021 May;94:104-110. 

Special Issue: The intersection of inflammation and metabolism in neuropsychiatric disorders. Felger JC, Capuron L.Brain Behav Immun. 2021 Mar;93:331-334. 

 

Multi-hit early life adversity affects gut microbiota, brain and behavior in a sex-dependent manner. Rincel M, Aubert P, Chevalier J, Grohard PA, Basso L, Monchaux de Oliveira C, Helbling JC, Lévy É, Chevalier G, Leboyer M, Eberl G, Layé S, Capuron L, Vergnolle N, Neunlist M, Boudin H, Lepage P, Darnaudéry M.Brain Behav Immun. 2019 Aug;80:179-192

 

Brain tumor necrosis factor-α mediates anxiety-like behavior in a mouse model of severe obesity. Fourrier C, Bosch-Bouju C, Boursereau R, Sauvant J, Aubert A, Capuron L, Ferreira G, Layé S, Castanon N.Brain Behav Immun. 2019 Mar;77:25-36. 

 

Inflammatory bases of neuropsychiatric symptom domains: mechanisms and specificity. Aouizerate, B., Vancassel, S., Castanon, N., Capuron, L., 2021 In: Immuno-Psychiatry. Facts and prospects. M. Berk, M. Leboyer, I. E. Sommer (eds), Springer, chapter 20, pp 335-353.

 

Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry. 

Fanet H, Capuron L, Castanon N, Calon F, Vancassel S.Curr Neuropharmacol. 2021;19(5):591-609. Review.